Amgen Receives CHMP Positive Opinions For Two New Treatment Options For Patients With Blood Cancer In Europe

Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...